Jack A. Khattar, President, CEO: Supernus Pharmaceuticals SUPN Sell · Filed 25/09/23

Trade details

Type: Insider sale
Amount: $779,920.74
Shares · price: 16,587 sh · $47.02 a share
Held after: 1,122,456 sh
Stock: Supernus Pharmaceuticals SUPN
Person: Jack A. KhattarPresident, CEO
Trade date: 25/09/22
Filed: 25/09/23
Days to filing: 1 days

Sold 1.5% of holdings

Share of holding sold: 1.5%

Supernus Pharmaceuticals trades, last 26 weeks

What else happened in Supernus Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/08/23~25/10/22

Jack A. Khattar's recent trades

Jack A. KhattarPresident, CEO
Sell10b5-1 planSupernus Pharmaceuticals
Sell10b5-1 plan
Supernus Pharmaceuticals
SUPN
$1.2M
24,138 sh
$1.2M
Filed 03/16
Traded 03/13
Jack A. KhattarPresident, CEO
Sell10b5-1 planSupernus Pharmaceuticals
Sell10b5-1 plan
Supernus Pharmaceuticals
SUPN
$547.8K
10,742 sh
$547.8K
Filed 03/16
Traded 03/13
Jack A. KhattarPresident, CEO
Sell10b5-1 planSupernus Pharmaceuticals
Sell10b5-1 plan
Supernus Pharmaceuticals
SUPN
$6,210
120 sh
$6,210
Filed 03/16
Traded 03/13
Jack A. KhattarDirector, Officer
Planned sale10b5-1 planSupernus Pharmaceuticals
Planned sale10b5-1 plan
Supernus Pharmaceuticals
SUPN
$1.8M
35,000 sh
$1.8M
Filed 03/13
Traded 03/13
Jack A. KhattarPresident, CEO
Sell10b5-1 planSupernus Pharmaceuticals
Sell10b5-1 plan
Supernus Pharmaceuticals
SUPN
$3M
58,371 sh
$3M
Filed 25/10/10
Traded 25/10/09